Insulin resistance is a major factor in the pathogenesis of type 2 diabetes mellitus and recent studies in humans and rodent models have strongly implicated a causative role for intracellular lipid metabolites in the pathogenesis of insulin resistance in liver and muscle. Furthermore recent in vivo nuclear magnetic resonance spectroscopy (NMR) studies by our group in humans have suggested that inherited defects in mitochondrial function in young lean insulin resistant offspring of parents with type 2 diabetes mellitus as well as acquired defects in lean healthy elderly subjects may be responsible for increased intracellular lipid accumulation and insulin resistance in these individuals. This grant will build on these findings and further explore the role of mitochondrial dysfunction and dysregulated intracellular fatty acid metabolism in causing insulin resistance in unique transgenic and knockout mouse models as well as in awake rats using a novel antisense oligonucleotide approach.
The specific aims that will be addressed in this proposal are: 1) To examine the role of muscle specific PGC1a and PGC1-3 over and under expression on insulin-stimulated rates of muscle glucose metabolism and muscle mitochondrial function, 2) To examine the impact of long chain CoA dehydrogenase deficiency in the pathogenesis of liver and muscle insulin resistance, 3) To examine the role of mitochondrial oxidative stress and mitochondrial DNA damage on mitochondrial function and insulin action, 4) To examine the individual roles of diacylglycerol acyl transferase 1 and diacylglycerol acyl transferase 2 on fat-induced hepatic insulin resistance, 5) To examine the role of protein kinase Ce in the pathogenesis of hepatic insulin resistance. All of these aims will be addressed in vivo using state-of-the-art methods including 31P, 13C and 1H NMR spectroscopy, liquid chromatography-tandem mass spectrometry in combination with radioactive isotopic techniques to obtain an integrated picture of whole-body glucose and energy metabolism as well as organ specific rates of insulin-stimulated glucose metabolism and mitochondrial function. It is anticipated that the results from these studies will provide important new insights into the role of mitochondrial dysfunction and alterations in intracellular fat oxidation in the pathogenesis of insulin resistance as well as identify potential novel targets for the prevention and treatment of type 2 diabetes mellitus. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK040936-20
Application #
7383938
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Laughlin, Maren R
Project Start
1988-12-01
Project End
2012-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
20
Fiscal Year
2008
Total Cost
$332,071
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Qiu, Yang; Perry, Rachel J; Camporez, João-Paulo G et al. (2018) In vivo studies on the mechanism of methylene cyclopropyl acetic acid and methylene cyclopropyl glycine-induced hypoglycemia. Biochem J 475:1063-1074
Jelenik, Tomas; Flögel, Ulrich; Álvarez-Hernández, Elisa et al. (2018) Insulin Resistance and Vulnerability to Cardiac Ischemia. Diabetes 67:2695-2702
Gassaway, Brandon M; Petersen, Max C; Surovtseva, Yulia V et al. (2018) PKC? contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling. Proc Natl Acad Sci U S A 115:E8996-E9005
Corbit, Kevin C; Camporez, João Paulo G; Edmunds, Lia R et al. (2018) Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling. Diabetes 67:208-221
Perry, Rachel J; Peng, Liang; Cline, Gary W et al. (2018) Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes. Cell Metab 27:210-217.e3
Samuel, Varman T; Shulman, Gerald I (2018) Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab 27:22-41
Price, Nathan L; Singh, Abhishek K; Rotllan, Noemi et al. (2018) Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance. Cell Rep 22:2133-2145
Perry, Rachel J; Wang, Yongliang; Cline, Gary W et al. (2018) Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation. Cell 172:234-248.e17
Vatner, Daniel F; Goedeke, Leigh; Camporez, Joao-Paulo G et al. (2018) Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia 61:1435-1446
Wang, Yongliang; Nasiri, Ali R; Damsky, William E et al. (2018) Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer. Cell Rep 24:47-55

Showing the most recent 10 out of 282 publications